mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> The success of mRNA vaccines against COVID-19 has catalyzed a paradigm shift in vaccinology. Messenger RNA (mRNA)-based platforms offer exceptional design flexibility, rapid manufacturing, and antigen-agnostic modularity, yet their full translational potential — spanning infectious disease prophylaxis, personalized cancer immunotherapy, and regulatory impleme...

Topics

Open a Topic to create a Post that cites this publication.

• Animal Virus Infections Studies
• Immunotherapy and Immune Responses
• RNA and protein synthesis mechanisms
• RNA Interference and Gene Delivery
• SARS-CoV-2 and COVID-19 Research
• Viral gastroenteritis research and epidemiology
• Viral Infections and Immunology Research
• Virus-based gene therapy research

Identifiers and source

Literature Corpus work

3cc06f36-a43b-5110-a959-b4ee48a32344

DOI

10.21203/rs.3.rs-9109248/v1